|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06826 HAOHAI BIOTEC
Nominal 
30.700 +0.100 (+0.327%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 5.945% | 2.607% | 5.317% | 3.696% | 7.004% |
| ROAE (%) | 7.454% | 3.215% | 6.288% | 4.204% | 8.179% |
| Return on Capital Employed (%) | 6.513% | 2.828% | 5.450% | 3.923% | 6.402% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 70.344% | 68.788% | 71.981% | 74.781% | 77.186% |
| EBITDA Margin (%) | 24.108% | 16.932% | 25.715% | 21.630% | 28.821% |
| Pre-tax Profit Margin (%) | 19.289% | 11.207% | 21.864% | 19.407% | 27.223% |
| Net Profit Margin (%) | 15.793% | 8.580% | 20.126% | 17.371% | 23.239% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 5.238 X | 6.908 X | 7.619 X | 8.784 X | 10.960 X |
| Quick Ratio (X) | 4.503 X | 5.959 X | 6.891 X | 8.195 X | 10.294 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 15.315% | 14.364% | 12.806% | 8.962% | 8.104% |
| Total Debt / Total Assets (%) | 5.741% | 1.716% | 1.518% | 1.716% | 0.808% |
| Net Debt / Total Assets (%) | -32.820% | -35.161% | -40.218% | -47.383% | -51.574% |
| Total Debt / Shareholders' Funds (%) | 7.220% | 2.144% | 1.847% | 1.968% | 0.911% |
| Long Term Debt / Shareholders' Funds (%) | 3.386% | 1.521% | 0.691% | 0.371% | 0.440% |
| Net Debt / Shareholders' Funds (%) | -41.275% | -43.946% | -48.924% | -54.355% | -58.165% |
| Net Cash / (Debt) ($) | 2.332B | 2.423B | 2.795B | 2.985B | 3.173B |
| Net Cash / (Debt) per share ($) | 13.600 | 13.918 | 15.898 | 16.842 | 17.840 |
| Total Debt / Capital Employed (%) | 6.385% | 1.853% | 1.633% | 1.843% | 0.858% |
| Interest Coverage Ratio (X) | 70.672 X | 32.004 X | 78.100 X | 53.401 X | 96.714 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 236.220 Day | 233.507 Day | 226.982 Day | 270.531 Day | 219.411 Day |
| Receivables Turnover (Day) | 50.240 Day | 66.242 Day | 74.659 Day | 100.693 Day | 88.628 Day |
| Payables Turnover (Day) | 7.594 Day | 8.745 Day | 7.747 Day | 8.932 Day | 8.918 Day |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 235,283 |
| %Change | 14.641% |
| EPS / (LPS) | RMB 1.010 |
| NBV Per Share (¥) | RMB 25.433 |